Senior insider sale
Chief Financial Officer at KESTRA MEDICAL TECHNOLOGIES, LTD. — senior position signals high conviction
$418.2K
18.19K shares
What this filing means
MAHBOOB VASEEM plans to sell 18.19K shares of KESTRA MEDICAL TECHNOLOGIES, LTD. valued at approximately $418.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/3/2026ACC: 0001964306-26-000359
Officer· Chief Financial Officer
Since Mar 2025
18.19K
Shares to sell
$418.2K
Approx. market value
5.39K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Vesting of performance share unit awards
Granted as part of issuer equity compensation plan
7/17/2026
5.39KTotal acquired5.39K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/17/2026 | Vesting of performance share unit awards Granted as part of issuer equity compensation plan | 5.39K | — |
| Total | 5.39K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
8.82K
Market value
$199.3K
7/31/2026
—Completed
Units to sell
3.98K
Market value
$90.6K
7/30/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
5.39K
Market value
$128.3K
8/3/2026
Total
Units
18.19K
Value
$418.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/31/2026 | 8.82K | $199.3K | — | Completed |
7/30/2026 | 3.98K | $90.6K | — | Completed |
| Planned — Approximate Date | ||||
8/3/2026 | 5.39K | $128.3K | NASDAQ | Planned |
| Total | 18.19K | $418.2K | ||